Rare circulating microRNAs as biomarkers of colorectal neoplasia

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Adams, Scott V ^a   Newcomb, Polly A ^a   Burnett Hartman, Andrea N ^a,b   Wurscher, Michelle A ^a   Mandelson, Margaret ^c   Upton, Melissa P ^c   Zhu, Lee Ching ^d   Potter, John D ^a,b,e   Makar, Karen W ^a  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d CENTER FOR HEALTH STUDIES   (United States)

^e MASSEY UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; TUMOR MARKER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD CELL; CANCER TISSUE; CASE CONTROL STUDY; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; COLORECTAL POLYP; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PLASMA; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; BLOOD; COLORECTAL TUMOR; CONFIDENCE INTERVAL; GENE EXPRESSION REGULATION; GENETICS; RISK;

AGED; CASE-CONTROL STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; ODDS RATIO; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84907821762     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108668     Document Type: Article

References (28)

1. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
2. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Nad Acad Sci U S A 105: 10513-10518.
3. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
4. Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
5. Luo X, Burwinkel B, Tao S, Brenner H (2011) MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol Biomarkers Prev 20: 1272 -1286.
6. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006.
7. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, et al. (2010) Circulating microRNAs in patients with coronary artery disease. Circ Res 107: 677-684.
8. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, et al. (2011) Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila).
9. Huang Z, Huang D, Ni S, Peng Z, Sheng W, et al. (2010) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. IntJ Cancer 127: 118-126.
10. Luo X, Stock C, Burwinkel B, Brenner H (2013) Identification and evaluation of plasma MicroRNAs for early detection of colorectal cancer. PLoS One 8: e62880.
11. Toiyama Y, Takahashi M, Hur K, Nagasaka T, Tanaka K, et al. (2013) Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J Natl Cancer Inst 105: 849-859.
12. Giraldez MD, Lozano JJ, Ramirez G, Hijona E, Bujanda L, et al. (2013) Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study. Clin Gastroenterol Hepatol 11: 681-688 e683.
13. Kanaan Z, Roberts H, Eichenberger MR, Billeter A, Ocheretner G, et al. (2013) A Plasma MicroRNA Panel for Detection of Colorectal Adenomas: A Step Toward More Precise Screening for Colorectal Cancer. Ann Surg 258: 400MB8.
14. Ahmed FE, Amed NC, Vos PW, Bonnerup C, Atkins JN, et al. (2012) Diagnostic microRNA markers to screen for sporadic human colon cancer in blood. Cancer Genomics Proteomics 9: 179-192.
15. Wang Q, Huang Z, Ni S, Xiao X, Xu Q, et al. (2012) Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. PLoS One 7: e44398.
16. Oberg AL, French AJ, Sarver AL, Subramanian S, Morlan BW, et al. (2011) miRNA expression in colon polyps provides evidence for a multihit model of colon cancer. PLoS One 6: e20465.
17. Bardey AN, Yao H, Barkoh BA, Ivan C, Mishra BM, et al. (2011) Complex patterns of altered MicroRNA expression during the adenoma-adenocarcinoma sequence for microsatellite-stable colorectal cancer. Clin Cancer Res 17: 7283 -7293.
18. Chia VM, Newcomb PA, Lampe JW, White E, Mandelson MT, et al. (2007) Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 16: 2697-2703.
19. Adams SV, Newcomb PA, Burnett-Hartman AN, White E, Mandelson MT, et al. (2011) Circulating 25-hydroxyvitamin-D and risk of colorectal adenomas and hyperplastic polyps. Nutr Cancer 63: 319-326.
20. Burnett-Hartman AN, Passarelli MN, Adams SV, Upton MP, Zhu LC, et al. (2013) Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site. Am J Epidemiol 177: 625-637.
21. Nishida N, Yokobori T, Mimori K, Sudo T, Tanaka F, et al. (2011) MicroRNA miR-125b is a prognostic marker in human colorectal cancer. Int J Oncol 38: 1437-1443.
22. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, et al. (2009) Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58: 1375-1381.
23. Kroh EM, Parkin RK, Mitchell PS, Tewari M (2010) Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50: 298-301.
24. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P (2004) Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 159: 882-890.
25. Cheng HH, Yi HS, Kim Y, Kroh EM, Chien JW, et al. (2013) Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS One 8: e64795.
26. Hindson CM, Chevillet JR, Briggs HA, Gallichotte EN, Ruf IK, et al. (2013) Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods 10: 1003-1005.
27. Taguchi YH, Murakami Y (2013) Principal component analysis based feature extraction approach to identify circulating microRNA biomarkers. PLoS One 8: e66714.
28. Keller A, Leidinger P, Bauer A, Elsharawy A, Haas J, et al. (2011) Toward the blood-borne miRNome of human diseases. Nat Methods 8: 841-843.